The efficacy of tumour necrosis factor-a antagonists in maintenance therapy for ulcerative colitis

被引：0
|
作者：
Ng, Alexander [1 ]
机构：
[1] UCL, Fac Laws, Gower St, London WC1E 6BT, England
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2021年 / 33卷
关键词：
D O I：
10.1097/MEG.0000000000002188
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E1088 / E1088
页数：1
相关论文
共 50 条
  • [41] Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
    D'Haens, Geert
    Dubinsky, Marla
    Kobayashi, Taku
    Irving, Peter M.
    Howaldt, Stefanie
    Pokrotnieks, Juris
    Krueger, Kathryn
    Laskowski, Janelle
    Li, Xingyuan
    Lissoos, Trevor
    Milata, Joe
    Morris, Nathan
    Arora, Vipin
    Milch, Catherine
    Sandborn, William
    Sands, Bruce E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (26): : 2444 - 2455
  • [42] Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
    Feagan, Brian G.
    Rutgeerts, Paul
    Sands, Bruce E.
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Sandborn, William J.
    Van Assche, Gert
    Axler, Jeffrey
    Kim, Hyo-Jong
    Danese, Silvio
    Fox, Irving
    Milch, Catherine
    Sankoh, Serap
    Wyant, Tim
    Xu, Jing
    Parikh, Asit
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 699 - 710
  • [43] Curcumin for maintenance therapy in ulcerative colitis - Reply
    Koide, Yukio
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (05) : 642 - 642
  • [44] Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    D'Haens, Geert
    Wolf, Douglas C.
    Jovanovic, Igor
    Hanauer, Stephen B.
    Ghosh, Subrata
    Petersen, AnnKatrin
    Hua, Steven Y.
    Lee, Ji Hwan
    Charles, Lorna
    Chitkara, Denesh
    Usiskin, Keith
    Colombel, Jean-Frederic
    Laine, Loren
    Danese, Silvio
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (14): : 1280 - 1291
  • [45] Infliximab for induction and maintenance therapy for ulcerative colitis
    Rutgeerts, P
    Sandborn, WJ
    Feagan, BG
    Reinisch, W
    Olson, A
    Johanns, J
    Travers, S
    Rachmilewitz, D
    Hanauer, SB
    Lichtenstein, GR
    de Villiers, WJS
    Present, D
    Sands, BE
    Colombel, JF
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23): : 2462 - 2476
  • [46] Comparative efficacy on mucosal healing of pharmacological therapies for moderate-to-severe ulcerative colitis, based on prior exposure to tumour necrosis factor antagonists: A systematic review and network meta-analysis
    Paschos, P.
    Katsoula, A.
    Giouleme, O.
    Tsapas, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S353 - S354
  • [47] ULCERATIVE COLITIS (UC) AND ANTI-TUMOUR NECROSIS FACTOR (A-TNF) THERAPY; A SINGLE UNIT'S REAL WORLD EXPERIENCE
    Steed, H.
    Rowlinson, A.
    Leslie, F.
    GUT, 2014, 63 : A77 - A77
  • [48] Demyelination Associated with Tumour Necrosis Factor alpha Antagonists
    O'Connell, Karen
    McGuigan, Christopher
    NEUROLOGY, 2013, 80
  • [49] Efficacy and safety of vedolizumab in the maintenance phase of ulcerative colitis
    Torralba, K. S.
    Payawal, D. A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 267 - 268
  • [50] Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
    Lukin, Dana
    Faleck, David
    Xu, Ronghui
    Zhang, Yiran
    Weiss, Aaron
    Aniwan, Satimai
    Kadire, Siri
    Tran, Gloria
    Rahal, Mahmoud
    Winters, Adam
    Chablaney, Shreya
    Koliani-Pace, Jenna L.
    Meserve, Joseph
    Campbell, James P.
    Kochhar, Gursimran
    Bohm, Matthew
    Varma, Sashidhar
    Fischer, Monika
    Boland, Brigid
    Singh, Siddharth
    Hirten, Robert
    Ungaro, Ryan
    Lasch, Karen
    Shmidt, Eugenia
    Jairath, Vipul
    Hudesman, David
    Chang, Shannon
    Swaminath, Arun
    Shen, Bo
    Kane, Sunanda
    Loftus, Edward, V
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Siegel, Corey A.
    Sandborn, William J.
    Dulai, Parambir S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (01) : 126 - 135
12345